{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:31:37Z","timestamp":1781213497479,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ijrobp.2017.04.022","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T12:46:38Z","timestamp":1493037998000},"page":"427-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma"],"prefix":"10.1016","volume":"99","author":[{"given":"J.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Litzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.T.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"C.B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.04.022_bib1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1634\/theoncologist.11-8-887","article-title":"Thymoma: Benign appearance, malignant potential","volume":"11","author":"Riedel","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.ijrobp.2011.03.010","article-title":"Evaluation of the role of radiation therapy in the management of malignant thymoma","volume":"82","author":"Patel","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/JTO.0b013e31821f9662","article-title":"Postoperative radiotherapy for completely resected stage II or III thymoma","volume":"6","author":"Chang","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2016.01.007","article-title":"Survival impact of adjuvant radiation therapy in Masaoka stage II to IV thymomas: A systematic review and meta-analysis","volume":"94","author":"Lim","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib5","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","article-title":"Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection","volume":"6","author":"Curran","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib6","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1002\/cncr.25851","article-title":"Adjuvant radiotherapy for completely resected stage 2 thymoma","volume":"117","author":"Berman","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib7","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","article-title":"Thymic tumors","volume":"77","author":"Detterbeck","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib8","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7","article-title":"Thymoma is associated with an increased risk of second malignancy","volume":"92","author":"Pan","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1097-0142(196811)22:6<1221::AID-CNCR2820220619>3.0.CO;2-7","article-title":"Thymoma and cancer","volume":"22","author":"Souadjian","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","article-title":"Intensity-modulated radiation therapy, protons, and the risk of second cancers","volume":"65","author":"Hall","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fonc.2014.00292","article-title":"Particle therapy for non-small cell lung tumors: Where do we stand? A systematic review of the literature","volume":"4","author":"Wink","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PPO.0000000000000080","article-title":"The use of proton therapy in the treatment of lung cancers","volume":"20","author":"Simone","year":"2014","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.radonc.2016.02.003","article-title":"Prospective study of proton beam radiatino therapy for adjuvant and definitive treamtent of thymoma and thymic carcinoma: Early response and toxicity assessment","volume":"118","author":"Vogel","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib14","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart","first-page":"148","article-title":"Tumours of the thymus","author":"M\u00fcller-Hermelink","year":"2004"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0360-3016(00)01555-8","article-title":"Methodologies and tools for proton beam design for lung tumors","volume":"49","author":"Moyers","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1078\/0939-3889-00242","article-title":"A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy","volume":"15","author":"Schneider","year":"2005","journal-title":"Z Med Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.12.040","article-title":"Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose","volume":"61","author":"Schneider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2007.02.029","article-title":"The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer","volume":"68","author":"Schneider","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jtho.2016.06.011","article-title":"Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma\u2014An analysis of the International Thymic Malignancies Interest Group retrospective database","volume":"11","author":"Rimner","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib20","unstructured":"Social Security. Retirement & survivors benefits: Life expectancy calculator. Available at: https:\/\/www.ssa.gov\/OACT\/population\/longevity.html. Accessed January 3,\u00a02017."},{"key":"10.1016\/j.ijrobp.2017.04.022_bib21","unstructured":"National Comprehensive Cancer Network. Thymomas and thymic carcinomas (version 3.2016). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/thymic.pdf. Accessed November 22,\u00a02016."},{"key":"10.1016\/j.ijrobp.2017.04.022_bib22","first-page":"165","article-title":"Recurrence of thymoma: Clinicopathological features, therapy, and prognosis","volume":"39","author":"Monden","year":"1985","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib23","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0003-4975(03)00819-1","article-title":"Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation","volume":"76","author":"Singhal","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jtcvs.2005.07.026","article-title":"Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size","volume":"130","author":"Wright","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib25","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ijc.11480","article-title":"Second primary cancers after thymoma","volume":"107","author":"Travis","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: Phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cllc.2014.12.001","article-title":"Intensity-modulated proton\u00a0therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: A dosimetric study","volume":"16","author":"Kesarwala","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2007.12.003","article-title":"Secondary neutrons in clinical proton radiotherapy: A charged issue","volume":"86","author":"Brenner","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijrobp.2010.11.021","article-title":"Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma","volume":"82","author":"Simone","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ijrobp.2009.07.011","article-title":"Radiation-induced cancers from modern radiotherapy techniques: Intensity-modulated radiotherapy versus proton therapy","volume":"77","author":"Yoon","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2008.04.069","article-title":"Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age","volume":"72","author":"Jarlskog","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2016.01.036","article-title":"Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer","volume":"95","author":"Chang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib33","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1120\/jacmp.v16i6.5678","article-title":"Beam-specific planning target volumes incorporating 4D CT for pencil beam scanning proton therapy of thoracic tumors","volume":"16","author":"Lin","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib34","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1088\/0031-9155\/55\/10\/006","article-title":"Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients","volume":"55","author":"Athar","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2017.04.022_bib35","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.0506648102","article-title":"Solid tumor risks after high doses of ionizing radiation","volume":"102","author":"Sachs","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161730826X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161730826X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T07:25:34Z","timestamp":1535873134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161730826X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S036030161730826X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.04.022","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}